Biopharma, doctors sue Trump administration over marijuana rescheduling
Source: SeekingAlpha
2026-06-02 10:38:03 ET
More on multi-state operators
- Curaleaf Benefits From Cannabis Rescheduling And International Growth
- Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling
- Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
- State AGs challenge Trump admin medical marijuana shift
- Curaleaf approves 1-for-3 reverse stock split for potential U.S. exchange uplisting
Read the full article on Seeking Alpha
For further details see:
Biopharma, doctors sue Trump administration over marijuana rescheduling
AdvisorShares Pure Cannabis ETF
NASDAQ: YOLO
YOLO Trading
4.98% G/L:
$3.16 Last:
38,478 Volume:
$3.12 Open:
YOLO Latest News
April 24, 2026 11:41:23 am
Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?
April 23, 2026 09:24:00 am
AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling
December 18, 2025 04:39:00 pm
AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis
